RESEARCHER PROFILE

Ulf Landmesser

← Back to Freie Universität Berlin

U

Freie Universität Berlin

Lipoproteins and Cardiovascular HealthCoronary Interventions and DiagnosticsCardiac Imaging and DiagnosticsAcute Myocardial Infarction ResearchAtrial Fibrillation Management and Outcomes

Ulf Landmesser works in Lipoproteins and Cardiovascular Health, Coronary Interventions and Diagnostics, Cardiac Imaging and Diagnostics, Acute Myocardial Infarction Research, Atrial Fibrillation Management and Outcomes. Recorded institutional associations include Humboldt-Universität zu Berlin, Deutsches Herzzentrum der Charité, German Centre for Cardiovascular Research.

1,147Publications
157,585Citations
136H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

    2021 · 13,353 citations
  2. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

    2020 · 9,971 citations
  3. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

    2019 · 8,976 citations
  4. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

    2015 · 8,274 citations
  5. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

    2015 · 6,930 citations
  6. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    2021 · 6,494 citations
  7. 2023 ESC Guidelines for the management of acute coronary syndromes

    2023 · 5,204 citations
  8. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

    2020 · 5,029 citations
  9. 2014 ESC/EACTS Guidelines on myocardial revascularization

    2014 · 4,199 citations
  10. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    2017 · 3,945 citations
  11. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

    2016 · 3,161 citations
  12. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

    2022 · 3,140 citations
  13. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

    2022 · 3,076 citations
  14. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

    2017 · 2,987 citations
  15. 2023 ESC Guidelines for the management of cardiomyopathies

    2023 · 2,755 citations
  16. 2020 ESC Guidelines for the management of adult congenital heart disease

    2020 · 2,311 citations
  17. 2023 ESC Guidelines for the management of endocarditis

    2023 · 1,754 citations
  18. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

    2003 · 1,655 citations
  19. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    2020 · 1,591 citations
  20. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

    2016 · 1,585 citations
  21. Role of oxidative stress in atherosclerosis

    2003 · 1,273 citations
  22. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

    2017 · 1,205 citations
  23. Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol

    2017 · 990 citations
  24. Mapping the human genetic architecture of COVID-19

    2021 · 983 citations
  25. A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy

    2007 · 906 citations

← Return to the university profile